These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 8370053)

  • 1. [Naftifin--laboratory and clinical experience with a new antimycotic from the allylamine group].
    Otcenásek M; Péc J; Moravcík P
    Cas Lek Cesk; 1993 Jun; 132(13):406-9. PubMed ID: 8370053
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Treatment of dermatomycosis with naftifin. Therapeutic effectiveness following once and twice daily administration].
    Meinicke K; Striegel C; Weidinger G
    Mykosen; 1984 Dec; 27(12):608-14. PubMed ID: 6395017
    [No Abstract]   [Full Text] [Related]  

  • 3. [Contact allergy to the antifungal agent naftifin].
    Hoting E; Küchmeister B; Hausen BM
    Derm Beruf Umwelt; 1987; 35(4):124-7. PubMed ID: 2959458
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Multicenter double-blind contralateral comparison of naftifin and clotrimazole cream in patients with dermatophytosis and candidiasis].
    Zaun H; Luszpinski P
    Z Hautkr; 1984 Sep; 59(18):1209-17. PubMed ID: 6388169
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antifungal activity of allylamine derivatives.
    Venugopal PV; Venugopal TV
    Indian J Med Res; 1994 Feb; 99():71-3. PubMed ID: 8005641
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Naftifin in severe dermatomycosis--controlled comparison of efficacy with econazole].
    Nolting S; Weidinger G
    Mykosen; 1985 Feb; 28(2):69-76. PubMed ID: 3885027
    [No Abstract]   [Full Text] [Related]  

  • 7. [Testing the sensitivity of opportunistic agents of mycoses to antimycotic drugs in vitro].
    Otcenásek M; Buchta V
    Cesk Epidemiol Mikrobiol Imunol; 1993 Mar; 42(1):29-34. PubMed ID: 8485769
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Evaluation of the efficacy of a new antimycotic molecule for topical use: naftifine].
    Albanese G; Giorgetti P; Santagostino L; Di Cintio R; Colombo MD
    G Ital Dermatol Venereol; 1989 May; 124(5):XXXIII-XXXVII. PubMed ID: 2620916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Allylamine antifungal drugs.
    Ryder NS; Mieth H
    Curr Top Med Mycol; 1992; 4():158-88. PubMed ID: 1732066
    [No Abstract]   [Full Text] [Related]  

  • 10. Azole antifungal agents related to naftifine and butenafine.
    Castellano S; La Colla P; Musiu C; Stefancich G
    Arch Pharm (Weinheim); 2000 Jun; 333(6):162-6. PubMed ID: 10909187
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Ketoconazole. 3 years' experience with a new orally active broadspectrum antimycotic].
    Haneke E
    Z Hautkr; 1982 Aug; 57(16):1165-76. PubMed ID: 6291267
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antifungal activity of steroidal glycosides from Yucca gloriosa L.
    Favel A; Kemertelidze E; Benidze M; Fallague K; Regli P
    Phytother Res; 2005 Feb; 19(2):158-61. PubMed ID: 15852482
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Croconazole: a new broad spectrum agent in the treatment of fungal skin infections.
    Meinicke K; Michel G
    Int J Clin Pharmacol Res; 1994; 14(4):139-48. PubMed ID: 7607787
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The antifungal agent naftifin. Placebo-controlled therapeutic comparison in tinea pedis].
    Klaschka F; Gartmann H; Weidinger G
    Z Hautkr; 1984 Sep; 59(18):1218-26. PubMed ID: 6388170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro activity of the lipopeptide derivative (Pal-Lys-Lys-NH), alone and in combination with antifungal agents, against clinical isolates of dermatophytes.
    Simonetti O; Arzeni D; Ganzetti G; Silvestri C; Cirioni O; Gabrielli E; Castelletti S; Kamysz W; Kamysz E; Scalise G; Offidani A; Barchiesi F
    Br J Dermatol; 2009 Aug; 161(2):249-52. PubMed ID: 19438437
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Naftifine. A review of its antimicrobial activity and therapeutic use in superficial dermatomycoses.
    Monk JP; Brogden RN
    Drugs; 1991 Oct; 42(4):659-72. PubMed ID: 1723367
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro evaluation of the antimycotic activity of a thiophene derivative.
    Riviera L; Bellotti MG; Valenti G
    Chemioterapia; 1984 Apr; 3(2):116-8. PubMed ID: 6532537
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vitro susceptibility testing of amorolfine in pathogenic fungi isolated from dermatomycosis patients in China.
    Li RY; Wan Z; Wang AP; Shen YN; Lu CM; Li M; Xi LY; Liu WD; Zeng FQ
    Mycoses; 2004 Oct; 47(9-10):402-6. PubMed ID: 15504124
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Allylamine derivatives: new class of synthetic antifungal agents inhibiting fungal squalene epoxidase.
    Petranyi G; Ryder NS; Stütz A
    Science; 1984 Jun; 224(4654):1239-41. PubMed ID: 6547247
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Naftifin in foot mycoses. Double-blind therapeutic comparison with clotrimazole].
    Haas PJ; Tronnier H; Weidinger G
    Mykosen; 1985 Jan; 28(1):33-40. PubMed ID: 3883160
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.